GLYCOMIMETICS

GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading researchers leverage their deep understanding of the role that carbohydrates play in cell recognition processes and use our proprietary chemistry platform to discover small molecule drugs, known as glycomimetics, which alter carbohydrate-mediated recognition in diverse disease states, including cancer and inflammation... GlycoMimetics is an oncology-focused biotechnology company. We are dedicated to improving the lives of patients living with orphan diseases.

Also known as: GlycoMimetics, Inc.

Primary location: Rockville United States